GIANNITRAPANI, Lydia
 Distribuzione geografica
Continente #
NA - Nord America 13.906
EU - Europa 12.948
AS - Asia 6.950
SA - Sud America 969
AF - Africa 237
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 11
Totale 35.052
Nazione #
US - Stati Uniti d'America 13.699
IT - Italia 6.035
SG - Singapore 2.450
RU - Federazione Russa 2.267
CN - Cina 1.770
FI - Finlandia 1.001
HK - Hong Kong 874
BR - Brasile 755
DE - Germania 747
UA - Ucraina 665
VN - Vietnam 649
PL - Polonia 429
FR - Francia 375
GB - Regno Unito 352
IE - Irlanda 330
JP - Giappone 237
NL - Olanda 179
BD - Bangladesh 167
IN - India 164
SE - Svezia 163
KR - Corea 119
CA - Canada 96
RO - Romania 93
TR - Turchia 85
BE - Belgio 79
AR - Argentina 70
MX - Messico 61
IQ - Iraq 58
CI - Costa d'Avorio 47
ES - Italia 47
AT - Austria 44
ZA - Sudafrica 44
PK - Pakistan 42
IR - Iran 41
UZ - Uzbekistan 34
MA - Marocco 32
VE - Venezuela 32
ID - Indonesia 31
EG - Egitto 28
CL - Cile 26
CO - Colombia 26
AU - Australia 25
PH - Filippine 25
DZ - Algeria 23
CH - Svizzera 22
MY - Malesia 22
NP - Nepal 22
AE - Emirati Arabi Uniti 20
AZ - Azerbaigian 20
EC - Ecuador 20
TN - Tunisia 19
CZ - Repubblica Ceca 18
SA - Arabia Saudita 17
GR - Grecia 15
KZ - Kazakistan 15
JO - Giordania 14
KE - Kenya 14
LB - Libano 14
LT - Lituania 14
PE - Perù 14
AL - Albania 13
RS - Serbia 11
PY - Paraguay 10
BG - Bulgaria 9
CR - Costa Rica 9
JM - Giamaica 9
DO - Repubblica Dominicana 7
ET - Etiopia 7
EU - Europa 7
UY - Uruguay 7
AM - Armenia 6
IL - Israele 6
NZ - Nuova Zelanda 6
PA - Panama 6
PS - Palestinian Territory 6
SN - Senegal 6
BH - Bahrain 5
BO - Bolivia 5
BY - Bielorussia 5
KG - Kirghizistan 5
PT - Portogallo 5
SV - El Salvador 5
DK - Danimarca 4
GE - Georgia 4
HU - Ungheria 4
KH - Cambogia 4
EE - Estonia 3
HN - Honduras 3
HR - Croazia 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
MN - Mongolia 3
MT - Malta 3
OM - Oman 3
QA - Qatar 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 35.009
Città #
Ashburn 1.764
Singapore 1.627
Fairfield 1.241
Chandler 1.002
San Jose 743
Woodbridge 661
Hong Kong 645
Houston 614
Wilmington 606
Ann Arbor 518
Seattle 487
Milan 451
Cambridge 405
Palermo 405
Moscow 377
Zgierz 362
Jacksonville 339
Dublin 327
Rome 305
Beijing 289
Des Moines 275
New York 257
Medford 255
Los Angeles 235
Tokyo 229
Ho Chi Minh City 216
Council Bluffs 213
Santa Clara 209
Frankfurt am Main 196
Dallas 189
Nanjing 189
Princeton 168
The Dalles 168
Hanoi 156
Naples 155
Lauterbourg 153
Altamura 143
Dearborn 110
Tulsa 98
Lawrence 97
Helsinki 96
San Diego 92
Hefei 89
Boardman 88
Buffalo 77
Florence 76
São Paulo 76
Shenyang 73
Brussels 71
Orem 67
Hebei 66
Jinan 65
Turin 63
Venice 62
Chicago 61
Nanchang 61
Falls Church 58
Verona 58
Tianjin 57
Changsha 55
Bologna 54
Munich 53
Nuremberg 50
London 49
Abidjan 47
Ludwigshafen am Rhein 45
Denver 42
Ningbo 42
Da Nang 41
Jiaxing 41
Catania 40
Warsaw 39
Chennai 37
Genoa 37
Cagliari 36
Amsterdam 34
Brooklyn 34
Phoenix 34
Toronto 34
Bari 33
Hangzhou 33
Zhengzhou 33
Columbus 32
Brescia 30
Atlanta 29
Campinas 29
Rio de Janeiro 29
Guangzhou 28
Izmir 28
Napoli 27
Padova 27
Johannesburg 26
Montreal 26
Redwood City 26
Kumar 25
Cardiff 24
Manchester 24
Salerno 24
San Paolo di Civitate 24
Turku 24
Totale 19.660
Nome #
Nodulo epatico ipovascolare: ruolo dell’ecografia nella diagnosi di HCC 4.254
MODIFICAZIONI ECOGRAFICHE DELLA LINFADENOPATIA DELL’ILO EPATICO DOPO ERADICAZIONE DELL’HCV CON DIRECT-ACTING ANTIVIRALS 547
PRESENTAZIONE ECOGRAFICA DELL’EPATOCARCINOMA: ESPERIENZA DI UN SINGOLO CENTRO NELL’ARCO DI TRE DECENNI 400
Clinical manifestations and outcome predictors of SARS-COV2 disease (COVID-19): experience of a single center. 392
ALLELIC VARIANTS OF CYP2E1 GENE IN HEPATOCARCINOMA PATIENTS AND IN HEPATIC TUMOR CELL LINES 386
A phenobarbital overdose: a case report 373
Clinical course and management of acute and chronic viral hepatitis during pregnancy. 295
Hepatocellular carcinoma: Comparison of two different periods at the same center 272
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection. 271
Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review 269
Surveillance program for diagnosis of hcc in liver cirrhosis: Role of ultrasound echo patterns 261
EFFETTI DELLA TERAPIA CON DIRECT ACTING ANTIVIRALS (DAAS) SUI PARAMETRI ECOGRAFICI DI IPERTENSIONE PORTALE 260
Ruolo dell'interazione NK/KIR nella storia naturale delle infezioni virali 259
Hemophagocytic syndrome in a patient with disseminated tuberculosis: A case report 257
An unusual Erdheim-Chester disease with orbital involvement: A case report 255
A key role for abdominal ultrasound examination in "difficult" diagnoses of celiac disease 253
Low-grade fever: how to distinguish organic from non-organic forms. 250
Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected mediterranean subjects 245
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study 245
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 241
Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome 240
Associated Factors and Liver Disease Severity for Decreased Bone Mineral Density in HIV Mono- and HIV/HCV Co-infected Patients 240
The health of irregular and illegal immigrants: analysis of day-hospital admissions in a department of migration medicine 238
Nontumorous portal vein thrombosis in liver cirrhosis: Possible role of β-blockers 234
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 232
Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia. 231
Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection 228
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases 227
Association Between Single Nucleotide Polymorphisms in the Cyclooxygenase-2, Tumor Necrosis Factor-a, and Vascular Endothelial Growth Factor-A Genes, and Susceptibility to Hepatocellular Carcinoma 225
Genetic determined down regulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer 224
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. 222
The Changing Epidemiology of Hepatocellular Carcinoma :  Experience of a Single Center 221
Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. 218
Abdominal US evaluation in celiac disease before and after a gluten-free diet 209
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 209
The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population 208
Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. 207
Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid 207
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells 205
Case report: acute portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent adult 202
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 202
Sex hormones and risk of liver tumor 201
Affidabilità del bright liver nella steatosi epatica in soggetti con ipertransaminasemia criptogenetica e con epatopatia da virus C 201
Interessamento epatico in corso di febbre bottonosa del Mediterraneo 201
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods 201
PREVALENCE OF LIVER DISEASES IN A POPULATION OF IMMIGRANTS IN SICILY. ANALYSIS OF DAY-HOSPITAL ADMISSIONS IN A DEPARTMENT OF MIGRATION MEDICINE 197
Leucocyte interferon-alpha for patients with chronic hepatitis C intolerant to other alpha-interferons 197
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 197
Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C. 196
Il bright liver echopattern come strumento diagnostico non invasivo di steatosi nell'ipertransaminasemia criptogenetica 195
Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study 194
Association between single nucleotide polymorphisms (SNPs) of IL-6, TNF-alpha and VEGF-A genes, and susceptibility to hepatocellular carcinoma (HCC) 194
Epidemiology, Diagnosis, and Non-Pharmacological Treatment of HCC 194
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 193
COMEPA (COVID-19 Medicina Policlinico Palermo): a study in hospitalized patients. 192
Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report. 191
Late-onset Sheehan's syndrome presenting with rhabdomyolysis and hyponatremia: a case report. 191
Hepatic expression of cyclooxygenase-2 in non alcoholic fatty liver disease 189
Association between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample 189
Affidabilità del Bright liver echopattern nella diagnosi di steatosi in pazienti con ipertransaminasemia criptogenetica 188
Circulating levels of molecular adhesion correlate with stage of renal disease and C-reactive protein in chronic kidney disease 188
IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. 187
Optimizing diagnostic approach to drug-induced liver injury 186
Benign and malignant mimickers of infiltrative hepatocellular carcinoma: tips and tricks for differential diagnosis on CT and MRI 186
Osteoporosis risk factors in HIV positive women with osteoporosis: A retrospective analysis 186
Minor hepatic resection for hepatocellular carcinoma in cirrhotic patients: Kelly clamp crushing resection versus heat coagulative necrosis with bipolar radiofrequency device 185
SCREENING DELL’EPATOCARCINOMA (HCC) NELLA CIRROSI EPATICA (CE): RUOLO DEI PATTERN ECOGRAFICI (US) 185
Cyclooxygenase- 2, Tumor Necrosis Factor-α, Vascular Endothelial Growth Factor-A and IL-6 genes SNPs and IL-6 serum levels in liver cirrhosis and hepatocellular carcinoma 185
Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of β-catenin and inhibition of β-catenin-mediated transactivation 184
Circulating intercellular adhesion molecule-1 in chronic hepatitis C patients with normal or elevated aminotransferase before and after alpha-interferon treatment 184
IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma 183
Liver disease severity and low bone mineral density in HIV mono-infected and HIV/HCV co-infected patients 182
A questionable diagnosis in a woman with drowsiness 182
Drammaturgia di un prurito 180
HepaDisk – A new quality of life questionnaire for HCV patients 180
Alteraziioni morfofunzionali vascolari in una popolazione con sindrome metabolica e steatosi epatica ecografica 179
The NF-kB inhibitors curcumin and DHMEQ exert antitumor synergy with cisplatin in hepatic cancer cells. Analysis of relationship to IL-6 production. 176
Variable Number of Tandem Repeats (VNTR) gene polymorphism of CYP2E1 in patients with pancreatic adenocarcinoma 176
Two single nucleotide polymorphisms in the MICA gene and sMICA plasma levels are associated with hepatocellular carcinoma development in an Italian population of HCV related liver cirrhosis 175
Affidabilità del bright liver nella diagnosi di steatosi epatica in pazienti con infezione da virus dell'immunodeficienza acquisita (HIV), da virus dell'epatite C (HCV) e coinfezione HCV/HIV: dati preliminari 173
SURVEILLANCE PROGRAM FOR DIAGNOSIS OF HCC IN LIVER CIRRHOSIS: ROLE OF ULTRASOUND ECHOPATTERNS 173
Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results. 173
Common polymorphisms in Th1 and Th2 cytokine genes and susceptibility to pancreatic adenocarcinoma 172
CEUS in the differential diagnosis between biliary sludge, benign lesions and malignant lesions 172
Genetic determined downregulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer 171
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 171
Effects of direct-acting antiviral therapy (DAAS) on the ultrasound parameters of portal hypertension 169
Waiting-time and quality of care deserved to patients with early stage hepatocellular carcinoma undergoing RFA treatment 168
New landscapes and horizons in hepatocellular carcinoma therapy 168
Non invasive tools for the diagnosis of liver cirrhosis 166
Long-term follow-up of hepatitis C virus-positive patients with persistently normal serum transaminases 165
Himpact of liver steatosis on the antiviral response in the hepatitis C virus –associated chronic hepatitis. 164
null 164
NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response 164
Distribution of liver disease in a cohort of immigrants in Sicily: analysis of day-hospital admissions in a migration medicine unit 162
Disfunzione endoteliale e malattia carotidea in pazienti con bright liver echopattern 161
Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease 161
Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis 161
Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study 158
VEGFR-2, HSP90 and GRP78/BiP expression and HCC recurrence after Liver Transplantation 157
Totale 25.277
Categoria #
all - tutte 106.017
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.017


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021229 0 0 0 0 0 0 0 0 0 0 0 229
2021/20222.206 109 385 81 95 102 137 91 125 286 289 127 379
2022/20233.673 328 476 80 333 306 458 263 527 360 84 232 226
2023/20243.286 169 340 218 293 245 414 279 221 100 396 249 362
2024/20254.708 220 377 294 480 302 230 369 289 337 442 588 780
2025/202611.988 896 338 649 930 1.181 1.839 1.765 1.289 1.015 1.526 540 20
Totale 35.879